Question follow-through · 83210
Abiraterone
To ask the Secretary of State for Health and Social Care, whether the NICE guidance on abiraterone produced in 2021 was based on abiraterone's cost in generic form.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 17 Oct 2025
- Target answer date
- 21 Oct 2025
- Answer
- 24 Oct 2025 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Respiratory Diseases: Health Services · 26 Nov 2025
- Vaccination: Finance · 1 Dec 2025
- Respiratory Syncytial Virus: Vaccination · 1 Dec 2025
- Alcoholic Drinks: Labelling · 1 Dec 2025
- Alcoholic Drinks: Labelling · 1 Dec 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
17 Oct 2025
Question tabled
To ask the Secretary of State for Health and Social Care, whether the NICE guidance on abiraterone produced in 2021 was based on abiraterone's cost in generic form.
21 Oct 2025
Target answer date
Date supplied by the official written-questions record.
24 Oct 2025
Answer published
The National Institute for Health and Care Excellence’s (NICE) published guidance on abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer, which has the reference code TA721, was developed before the patent for a...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Respiratory Diseases: Health Services
26 Nov 2025 · To ask the Secretary of State for Health and Social Care, whether his Department plans to publish a modern service framework for respiratory health.
Vaccination: Finance
1 Dec 2025 · To ask the Secretary of State for Health and Social Care, what proportion of NHS England’s total budget has been allocated to vaccination and immunisation programmes in each of the last five years.
Respiratory Syncytial Virus: Vaccination
1 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he made of the difference in uptake rates between maternal and infant RSV immunisations when developing the national immunisation programme.
Alcoholic Drinks: Labelling
1 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has assessed the importance of including accessible behaviour-change and drinking moderation tools, including links to digital health support, as part of the new mandatory al
Alcoholic Drinks: Labelling
1 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has assessed how alcohol labelling reforms could support local public-health and community-based initiatives aimed at reducing alcohol-related harm, particularly in areas wit
Abiraterone
1 Dec 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 October 2025 to Question 83204, what step he is taking to secure a recurrent budget for abiraterone in high risk, non-metastatic prostate cancer, in the context of it b
Respiratory Diseases: Health Services
1 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of developing a Modern Service Framework for respiratory health.
Ophthalmic Services
3 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the provision of a Minor Eye Conditions Service in every part of the country.
Ophthalmic Services
3 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of the (a) Minor Eye Conditions Service and (b) Community Urgent Eyecare Service.
Ophthalmic Services
3 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the (a) Minor Eye Conditions Service and (b) Community Urgent Eyecare Service on (i) patient outcomes and (ii) unnecessary referra
Ophthalmic Services
3 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of eye care services.
Ophthalmic Services
3 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of steps taken by Integrated Care Boards to address regional inequalities in access to eye care services.